Akorn, Inc. was a big mover last session, as the company saw its shares rise more than 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This stock, trading within a volatile range of $15.04–$18.58 in the past one-month time frame, showed a sharp increase yesterday.

The company has not seen any estimate revisions over the past month, while the Zacks Consensus Estimate for the current quarter also remained unchanged. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Akorn currently has a Zacks Rank #3 (Hold), while its Earnings ESP is 0.00%.

Investors interested in the Medical - Generic Drugs industry may consider Aquinox Pharmaceuticals, Inc. , which currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Is AKRX going up? Or down? Predict to see what others think: Up or Down

5 Medical Stocks to Buy Now

Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.

New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.

Click here to see the 5 stocks >>